产品编号 :
Cas No. :
CAS No. |
181816-48-8 |
|---|---|
中文名称 |
(S,Z)-2-氨基-3-羟基-N-[2-甲氧基-5-(3,4,5-三甲氧基苯乙烯基)苯基]丙酰胺 |
英文名称 |
(S,Z)-2-Amino-3-hydroxy-N-(2-methoxy-5-(3,4,5-trimethoxystyryl)phenyl)propanamide |
别名 |
ombrabulin;(2S)-2-Amino-3-hydroxy-N-[2-methoxy-5-[(1Z)-2-(3,4,5-trimethoxyphenyl)ethenyl]phenyl]propanamide;PropanaMide,2-aMino-3-hydroxy-N-[2-Methoxy-5-[(1Z)-2-(3,4,5-triMethoxyphenyl)ethenyl]phenyl]-,(2S)-;AVE-8062;OMbrabulin(AVE-8062);AVE8062;AC-7700;CS-39-L-SER.HCL;AVE-8062A;AVE-8062;RPR-258062A.;CS-39-L-Ser.HCl;RPR-258062A. |
标准英文名 |
(S,Z)-2-amino-3-hydroxy-N-(2-methoxy-5-(3,4,5-trimethoxystyryl)phenyl)propanamide |
分子式 |
C21H26N2O6 |
分子量 |
402.45 |
精确分子量 |
402.18 |
SMILES |
O=C(NC1=CC(/C=C\C2=CC(OC)=C(OC)C(OC)=C2)=CC=C1OC)[C@@H](N)CO |
标准SMILES |
COC1C=C(C=C(OC)C=1OC)/C=C\C1C=C(NC(=O)[C@@H](N)CO)C(=CC=1)OC |
用途 |
Ombrabulin (AVE8062) is a vascular disrupting agent (VDA) belonging to the combretastatin family, used for its anti-angiogenic activity by selectively disrupting the tubulin cytoskeleton in endothelial cells; it can be administered in combination with docetaxel and cisplatin for cancer therapy, with recommended dosing regimens of ombrabulin at 20 or 35 mg/m², docetaxel at 75 mg/m², and cisplatin at 75 mg/m²; preclinical studies demonstrate its efficacy in reducing tumor weight in ovarian cancer xenograft models, with a 65% reduction observed at a dose of 30 mg/kg administered intraperitoneally twice weekly. |
InChIKey |
IXWNTLSTOZFSCM-YVACAVLKSA-N |
|
|
评论 |
|---|